Report Detail
Global Glaucoma Treatment Market Growth (Status and Outlook) 2019-2024
- RnM3206171 |
- 28 March, 2019 |
- Global |
- 116 Pages |
- LPI(LP Information) |
- Other
Glaucoma can be treated with eye drops, pills, laser surgery, traditional surgery or a combination of these methods. The goal of any treatment is to prevent loss of vision, as vision loss from glaucoma is irreversible.
In the last several years, Hong Kong market of Glaucoma Treatment developed rapidly, with an average growth rate of 4% during 2013 to 2018. In 2018, Hong Kong revenue of Glaucoma Treatment is nearly 73 M USD.
The classification of Glaucoma Treatment includes Prostaglandin Analogs (PGAs), Beta Blocker, Alpha Agonist and other, and the proportion of Prostaglandin Analogs (PGAs) in 2018 is about 52%, and the proportion is in increasing trend from 2013 to 2018.
Glaucoma Treatment is widely used in Clinic, Pharmacy and other field. The most proportion of Glaucoma Treatment is in hospitals, and the proportion in 2018 is 66%.
According to this study, over the next five years the Glaucoma Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Glaucoma Treatment business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Glaucoma Treatment market by product type, application, key companies and key regions.
This study considers the Glaucoma Treatment value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Prostaglandin Analogs (PGAs)
Beta Blocker
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Clinic
Pharmacy
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
Allergan
Pfizer
Akorn
Teva
Bausch & Lomb
Otsuka Pharmaceutical
Santen
Lunan Pharma
Zizhu Pharma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Glaucoma Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Glaucoma Treatment market by identifying its various subsegments.
Focuses on the key global Glaucoma Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Glaucoma Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Glaucoma Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Glaucoma Treatment Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Glaucoma Treatment Market Size 2014-2024
- 2.1.2 Glaucoma Treatment Market Size CAGR by Region
- 2.2 Glaucoma Treatment Segment by Type
- 2.2.1 Prostaglandin Analogs (PGAs)
- 2.2.2 Beta Blocker
- 2.2.3 Alpha Agonist
- 2.3 Glaucoma Treatment Market Size by Type
- 2.3.1 Global Glaucoma Treatment Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Glaucoma Treatment Market Size Growth Rate by Type (2014-2019)
- 2.4 Glaucoma Treatment Segment by Application
- 2.4.1 Clinic
- 2.4.2 Pharmacy
- 2.4.3 Other
- 2.5 Glaucoma Treatment Market Size by Application
- 2.5.1 Global Glaucoma Treatment Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Glaucoma Treatment Market Size Growth Rate by Application (2014-2019)
3 Global Glaucoma Treatment by Players
- 3.1 Global Glaucoma Treatment Market Size Market Share by Players
- 3.1.1 Global Glaucoma Treatment Market Size by Players (2017-2019)
- 3.1.2 Global Glaucoma Treatment Market Size Market Share by Players (2017-2019)
- 3.2 Global Glaucoma Treatment Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Glaucoma Treatment by Regions
- 4.1 Glaucoma Treatment Market Size by Regions
- 4.2 Americas Glaucoma Treatment Market Size Growth
- 4.3 APAC Glaucoma Treatment Market Size Growth
- 4.4 Europe Glaucoma Treatment Market Size Growth
- 4.5 Middle East & Africa Glaucoma Treatment Market Size Growth
5 Americas
- 5.1 Americas Glaucoma Treatment Market Size by Countries
- 5.2 Americas Glaucoma Treatment Market Size by Type
- 5.3 Americas Glaucoma Treatment Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Glaucoma Treatment Market Size by Countries
- 6.2 APAC Glaucoma Treatment Market Size by Type
- 6.3 APAC Glaucoma Treatment Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Glaucoma Treatment by Countries
- 7.2 Europe Glaucoma Treatment Market Size by Type
- 7.3 Europe Glaucoma Treatment Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Glaucoma Treatment by Countries
- 8.2 Middle East & Africa Glaucoma Treatment Market Size by Type
- 8.3 Middle East & Africa Glaucoma Treatment Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Glaucoma Treatment Market Forecast
- 10.1 Global Glaucoma Treatment Market Size Forecast (2019-2024)
- 10.2 Global Glaucoma Treatment Forecast by Regions
- 10.2.1 Global Glaucoma Treatment Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Glaucoma Treatment Forecast by Type
- 10.8 Global Glaucoma Treatment Forecast by Application
11 Key Players Analysis
- 11.1 Novartis
- 11.1.1 Company Details
- 11.1.2 Glaucoma Treatment Product Offered
- 11.1.3 Novartis Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Novartis News
- 11.2 Allergan
- 11.2.1 Company Details
- 11.2.2 Glaucoma Treatment Product Offered
- 11.2.3 Allergan Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Allergan News
- 11.3 Pfizer
- 11.3.1 Company Details
- 11.3.2 Glaucoma Treatment Product Offered
- 11.3.3 Pfizer Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Pfizer News
- 11.4 Akorn
- 11.4.1 Company Details
- 11.4.2 Glaucoma Treatment Product Offered
- 11.4.3 Akorn Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Akorn News
- 11.5 Teva
- 11.5.1 Company Details
- 11.5.2 Glaucoma Treatment Product Offered
- 11.5.3 Teva Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Teva News
- 11.6 Bausch & Lomb
- 11.6.1 Company Details
- 11.6.2 Glaucoma Treatment Product Offered
- 11.6.3 Bausch & Lomb Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Bausch & Lomb News
- 11.7 Otsuka Pharmaceutical
- 11.7.1 Company Details
- 11.7.2 Glaucoma Treatment Product Offered
- 11.7.3 Otsuka Pharmaceutical Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Otsuka Pharmaceutical News
- 11.8 Santen
- 11.8.1 Company Details
- 11.8.2 Glaucoma Treatment Product Offered
- 11.8.3 Santen Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Santen News
- 11.9 Lunan Pharma
- 11.9.1 Company Details
- 11.9.2 Glaucoma Treatment Product Offered
- 11.9.3 Lunan Pharma Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Lunan Pharma News
- 11.10 Zizhu Pharma
- 11.10.1 Company Details
- 11.10.2 Glaucoma Treatment Product Offered
- 11.10.3 Zizhu Pharma Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Zizhu Pharma News
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Glaucoma Treatment. Industry analysis & Market Report on Glaucoma Treatment is a syndicated market report, published as Global Glaucoma Treatment Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Glaucoma Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
